78 related articles for article (PubMed ID: 30936202)
1. A small-molecule inhibitor of the DNA recombinase Rad51 from
Vydyam P; Dutta D; Sutram N; Bhattacharyya S; Bhattacharyya MK
J Biol Chem; 2019 May; 294(20):8171-8183. PubMed ID: 30936202
[TBL] [Abstract][Full Text] [Related]
2. Characterization of kinetics of DNA strand-exchange and ATP hydrolysis activities of recombinant PfRad51, a Plasmodium falciparum recombinase.
Bhattacharyya MK; Bhattacharyya nee Deb S; Jayabalasingham B; Kumar N
Mol Biochem Parasitol; 2005 Jan; 139(1):33-9. PubMed ID: 15610817
[TBL] [Abstract][Full Text] [Related]
3. The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin.
Kumar R; Musiyenko A; Barik S
Malar J; 2003 Sep; 2():30. PubMed ID: 14514358
[TBL] [Abstract][Full Text] [Related]
4. Identification and molecular characterisation of DNA damaging agent induced expression of Plasmodium falciparum recombination protein PfRad51.
Bhattacharyya MK; Kumar N
Int J Parasitol; 2003 Oct; 33(12):1385-92. PubMed ID: 14527521
[TBL] [Abstract][Full Text] [Related]
5. Mutation in the 26S proteasome regulatory subunit
Gonçalves AF; Lima-Pinheiro A; Teixeira M; Cassiano GC; Cravo P; Ferreira PE
Front Cell Infect Microbiol; 2024; 14():1342856. PubMed ID: 38404287
[TBL] [Abstract][Full Text] [Related]
6. A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeutic agents in mouse xenografts.
Huang F; Mazin AV
PLoS One; 2014; 9(6):e100993. PubMed ID: 24971740
[TBL] [Abstract][Full Text] [Related]
7. MYST regulates DNA repair and forms a NuA4-like complex in the malaria parasite
Kalamuddin M; Shakri AR; Wang C; Min H; Li X; Cui L; Miao J
mSphere; 2024 Apr; 9(4):e0014024. PubMed ID: 38564734
[TBL] [Abstract][Full Text] [Related]
8. Design, in silico study, synthesis and evaluation of hybrid pyrazole substituted 1,3,5-triazine derivatives for antimalarial activity.
Borgohain P; Shakya A; Ghosh SK; Gogoi N; Patgiri SJ; Bhowmick IP; Bhattacharyya DR; Singh UP; Bhat HR
Exp Parasitol; 2024 Jun; 261():108767. PubMed ID: 38679125
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Iso-Mukaadial Acetate and Ursolic Acid Acetate as
Opoku F; Govender PP; Pooe OJ; Simelane MBC
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835879
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Patel V; Booker M; Kramer M; Ross L; Celatka CA; Kennedy LM; Dvorin JD; Duraisingh MT; Sliz P; Wirth DF; Clardy J
J Biol Chem; 2008 Dec; 283(50):35078-85. PubMed ID: 18842591
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Plasmodium falciparum ubc13 increases parasite sensitivity to the mutagen, methyl methanesulfonate and dihydroartemisinin.
Maneekesorn S; Knuepfer E; Green JL; Prommana P; Uthaipibull C; Srichairatanakool S; Holder AA
Sci Rep; 2021 Nov; 11(1):21791. PubMed ID: 34750454
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors.
Phuangsawai O; Beswick P; Ratanabunyong S; Tabtimmai L; Suphakun P; Obounchoey P; Srisook P; Horata N; Chuckowree I; Hannongbua S; Ward SE; Choowongkomon K; Gleeson MP
Eur J Med Chem; 2016 Nov; 124():896-905. PubMed ID: 27668758
[TBL] [Abstract][Full Text] [Related]
13. Competitive Inhibition of Okanin against
Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970
[TBL] [Abstract][Full Text] [Related]
14. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.
Deni I; Stokes BH; Ward KE; Fairhurst KJ; Pasaje CFA; Yeo T; Akbar S; Park H; Muir R; Bick DS; Zhan W; Zhang H; Liu YJ; Ng CL; Kirkman LA; Almaliti J; Gould AE; Duffey M; O'Donoghue AJ; Uhlemann AC; Niles JC; da Fonseca PCA; Gerwick WH; Lin G; Bogyo M; Fidock DA
Cell Chem Biol; 2023 May; 30(5):470-485.e6. PubMed ID: 36963402
[TBL] [Abstract][Full Text] [Related]
15. Targeting the
King HR; Bycroft M; Nguyen TB; Kelly G; Vinogradov AA; Rowling PJE; Stott K; Ascher DB; Suga H; Itzhaki LS; Artavanis-Tsakonas K
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2322923121. PubMed ID: 38739798
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the interaction of antimalarial agents with Plasmodium falciparum glutathione reductase through molecular mechanical calculations.
Ferreira FHDC; Pinto LR; Oliveira BA; Daniel LV; Navarro M; Delgado GYS
J Mol Model; 2024 May; 30(6):181. PubMed ID: 38780838
[TBL] [Abstract][Full Text] [Related]
17. High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of
Johannsen S; Gierse RM; Krüger A; Edwards RL; Nanna V; Fontana A; Zhu D; Masini T; de Carvalho LP; Poizat M; Kieftenbelt B; Hodge DM; Alvarez S; Bunt D; Lacour A; Shams A; Meissner KA; de Souza EE; Dröge M; van Vliet B; den Hartog J; Hutter MC; Held J; Odom John AR; Wrenger C; Hirsch AKH
ACS Infect Dis; 2024 Mar; 10(3):1000-1022. PubMed ID: 38367280
[TBL] [Abstract][Full Text] [Related]
18. Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.
Legru A; Batista FA; Puszko AK; Bouillon A; Maurel M; Martinez M; Ejjoummany A; Ortega Varga L; Adler P; Méchaly A; Hadjadj M; Sosnowski P; Hopfgartner G; Alzari PM; Blondel A; Haouz A; Barale JC; Hernandez JF
Eur J Med Chem; 2024 Apr; 269():116308. PubMed ID: 38503166
[TBL] [Abstract][Full Text] [Related]
19. A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation.
Ojo KK; Eastman RT; Vidadala R; Zhang Z; Rivas KL; Choi R; Lutz JD; Reid MC; Fox AM; Hulverson MA; Kennedy M; Isoherranen N; Kim LM; Comess KM; Kempf DJ; Verlinde CL; Su XZ; Kappe SH; Maly DJ; Fan E; Van Voorhis WC
J Infect Dis; 2014 Jan; 209(2):275-84. PubMed ID: 24123773
[TBL] [Abstract][Full Text] [Related]
20. Access to Artemisinin-Triazole Antimalarials
Herrmann L; Leidenberger M; Quadros HC; Grau BW; Hampel F; Friedrich O; Moreira DRM; Kappes B; Tsogoeva SB
JACS Au; 2024 Mar; 4(3):951-957. PubMed ID: 38559731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
